Skip to search boxSkip to navigationSkip to main content

Epidemiology of systemic lupus erythematosus

  • Grupo Oroño-Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR)
    ,
  • Hospital Clinic Barcelona
    ,
  • ,
  • Universidad Científica del Sur
    ,
  • Hospital Guillermo Almenara Irigoyen
    ,
  • The University of Alabama at Birmingham
Research Output:
Contribution to journal
Review article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 799-814 (16 pages)

Journal (Volume, Issue Number)

Expert Review of Clinical Immunology (Volume 13, Issue 8)

Publication milestones

  • Published - 03/08/2017

Publication status

Published - 03/08/2017

ISSN

1744-666X

Publication IDs

  • Scopus: 85024505003
  • PubMed: 28471259

Abstract

Introduction: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which occurs in both genders, and across racial/ethnic and age groups; however, higher rates are observed in adults, in women and in non-Caucasians. Genetic, environmental, sociodemographic and methodological issues are responsible not only for these differences but for the variable course and outcome of the disease. Non-Caucasians have a more severe disease with a higher risk for early mortality and damage accrual. Males also have a more severe disease; however, a negative impact of male gender on lupus outcomes has not been firmly established. Childhood-onset is associated with a more severe disease; moreover, it is also associated with higher damage and diminished survival; finally, late-onset lupus is mild but it is associated with higher damage accrual and a diminished survival. Areas covered: In this review, we discuss the incidence and prevalence of SLE, the impact of age, gender and race/ethnicity in SLE and in the survival of those affected. Expert commentary: Age, gender and race/ethnicity impact disease expression in SLE patients; despite improvements in survival, mortality in SLE remains almost three times higher than in the general population.

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
180
Captures
553
Mentions
2